KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Gains from Investment Securities (2016 - 2025)

Sabra Health Care REIT (SBRA) has 14 years of Gains from Investment Securities data on record, last reported at -$5.9 million in Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 118380.0% year-over-year to -$5.9 million; the TTM value through Dec 2025 reached -$7000.0, up 75.86%, while the annual FY2025 figure was -$7000.0, 75.86% up from the prior year.
  • Gains from Investment Securities reached -$5.9 million in Q4 2025 per SBRA's latest filing, down from $5.9 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $164.1 million in Q2 2021 and bottomed at -$162.1 million in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $405578.9, with a median of -$3000.0 recorded in 2025.
  • Peak YoY movement for Gains from Investment Securities: soared 29625.0% in 2024, then plummeted 118380.0% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$162.1 million in 2021, then skyrocketed by 101.41% to $2.3 million in 2022, then skyrocketed by 35.19% to $3.1 million in 2023, then crashed by 100.16% to -$5000.0 in 2024, then tumbled by 118380.0% to -$5.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were -$5.9 million in Q4 2025, $5.9 million in Q3 2025, and -$3000.0 in Q2 2025.